<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04220164</url>
  </required_header>
  <id_info>
    <org_study_id>18MMHIS083e</org_study_id>
    <nct_id>NCT04220164</nct_id>
  </id_info>
  <brief_title>Observation of Blood Lipid Outcomes in Lipid Clinic</brief_title>
  <official_title>Observation of Blood Lipid Outcomes in Patients Who Receive Treatment in Lipid Clinic of Taipei MacKay Memorial Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In
      this Lipid Clinic, the physician will discuss with each individual patient and set an
      individualized LDL goal according to current guideline and regulation of National Health
      Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in
      patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperlipidemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD), and
      therefore it is beneficial to prevent the risk of ASCVD by controlling the prevalence of
      hyperlipidemia. According to CEPHEUS Pan-Asia survey, the rate of LDL goal attainment in
      hyperlipidemic patients of Taiwan was suboptimal, especially in high-risk patients. 2017
      Taiwan lipid guideline for high-risk patients has been published and clearly defined the
      treatment goal of blood LDL-C for high-risk patients. Besides, Taipei MacKay Memorial
      Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the
      physician will discuss with each individual patient and set an individualized LDL goal
      according to current guideline and regulation of National Health Insurance Administration
      (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive
      treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 3, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>12 month</time_frame>
    <description>check serum level of LDL-C</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Dyslipidemic patients</arm_group_label>
    <description>Patients who meet the criteria of high-risk category according to 2017 Taiwan Lipid Guideline for High-Risk Patients have a abnormal serum LDL-C level</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Education and inform the optimal threshold of LDL-C levels</intervention_name>
    <description>Physicians educate patients and provide a clear information about optimal LDL-C value according to individual patient's condition according to current guidelines</description>
    <arm_group_label>Dyslipidemic patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are ≥20 years, have abnormal lipid profiles, need lipid-lowering drugs
        according to 2017 Taiwan Lipid Guideline in Lipid Clinic of Taipei MacKay Memorial
        Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥20 years-old

          -  Abnormal lipid profiles according to 2017 Taiwan Lipid Guideline for High-risk
             Patients

        Exclusion Criteria

          -  Reject to participate in this study

          -  Pregnant women

          -  Prisoner

          -  Illiteracy

          -  HIV patients

          -  Individuals who are mentally retarded, homeless, and handicapped
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chao-Feng Lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mackay Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ting-Yun Lu</last_name>
    <phone>886-2-25433535</phone>
    <phone_ext>3256</phone_ext>
    <email>tingyunlu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chao-Feng Lin, PhD</last_name>
    <phone>886-2-25433535</phone>
    <phone_ext>3256</phone_ext>
    <email>thcpci@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Taiwan, Taipei, Mackay Memorial hospital</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ting-Yun Lu</last_name>
      <phone>886-2-25433535</phone>
      <phone_ext>3256</phone_ext>
      <email>tingyunlu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients. 2017 Taiwan lipid guidelines for high risk patients. J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. Review. Erratum in: J Formos Med Assoc. 2018 Aug;117(8):749-750.</citation>
    <PMID>28242176</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 26, 2019</study_first_submitted>
  <study_first_submitted_qc>January 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 3, 2020</last_update_submitted>
  <last_update_submitted_qc>January 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We will not provide IPD to other researchers according to IRB regulation.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

